TotalMarketCap

Tenax Therapeutics

TENXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$61.188 M

$1.64 -9.67%

Close of 6 Nov 2026

As of 6 Nov 2026, Tenax Therapeutics (TENX) has a market capitalization of $61.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$52.6M

Loss-making

Shares outstanding

45,536,448

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #315CingulateCING$61.4M
  2. #316Fortress BiotechFBIO$61.4M
  3. #317Tenax TherapeuticsTENX$61.2M
  4. #318Quantum CyberQUCY$60.6M
  5. #319Spero TherapeuticsSPRO$59.3M

What if Tenax Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$754,514.12

Per share 461,477× higher

Bitcoin $1.53T

$40,825.45

Per share 24,970× higher

Apple $5.02T

$134,026.13

Per share 81,973× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Tenax Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.